my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
ACQUITY PREMIER is specifically designed to improve analyte recovery, reproducibility and sensitivity by minimizing unwanted interactions with the surface that can lead to sample loss - all without time-consuming tasks such as system and column passivation.
Don't deal with long passivation and conditioning times, poor sensitivity, poor peak shapes, complex mobile phases, or high variability from injection to injection and day to day. Make informed decisions and reduce risk as your analyses capture more sample components from the start. Achieve the highest limits of detection, consistent results, and better recovery.
Whether you are working with peptides, glycans, or modified oligos, screening or quantifying small molecules, or detecting or validating biomarkers, ACQUITY Premier helps you get results faster, shorten method development time, and increase overall lab efficiency.
A universal platform for liquid chromatography
Faster, more reproducible, and accurate data integration with challenging molecules ✓ Shorter time from sample to result, without conditioning ✓ Improved compliance from higher quality data ✓ more
Performance you need, Results you can trust
Ever-evolving regulations are impacting LC method approaches for product quality control and beyond. Count on the Arc HPLC System for high-efficiency separations and quality data to help meet your regulatory requirements with confidence. Arc HPLC allows you to easily replicate and improve t ... more
Did you know that metal interactions can put your analytical results at RISK?
Non-specific adsorption (NSA) of metal sensitive analytes can lead to loss of sensitivity, poor peak shape, poor reproducibility and lengthy passivation procedures. The occurrence of these NSA losses can be hard to predict and therefore, a good plan to mitigate them leads to less risk and ... more
Waters Appoints John M. Ballbach to Board of Directors
Waters Corporation announced the appointment of John M. Ballbach to its Board of Directors, effective October 5, 2021. Mr. Ballbach currently serves on the Board of RPM International, Inc., a leader in specialty coatings, sealants, building materials and related services. Waters also announ ... more
Waters Corporation Appoints Pearl S. Huang to Board of Directors
Waters Corporation announced that Dr. Pearl S. Huang, President and CEO of Cygnal Therapeutics and venture partner at Flagship Pioneering, has been appointed as a Director of Waters Corporation, effective January 1, 2021. “We are pleased to welcome Pearl to the Waters Board of Directors,” ... more
Waters Corporation has formally expanded its long-standing, collaborative relationship with Dr. Sunghwan Kim of Kyungpook National University to further explore the use of Waters’ cutting-edge ion mobility spectrometry (IMS) in the investigation of compounds in complex mixtures. Identifying ... more
Waters Corporation is a global leader in liquid chromatography (UPLC/HPLC), mass spectrometry (MS), rheology and thermal analysis. The business areas range from research & development, the manufacture and sale of analytical instruments, laboratory software products, column and sample prepar ... more
Waters Corporation creates business advantage for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide. Pioneering a c ... more
Since 1958 Waters offers complete solutions in High Performance Liquid Chromatography (HPLC). With our products and services we set the standards in HPLC. Waters Corporation is a multinational, publicly traded (NYSE: WAT) company headquartered in Milford, Massachusetts, USA. The company ha ... more
